舒芬太尼复合罗哌卡因用于潜伏期硬膜外分娩镇痛的临床效果分析

Clinical effect of sufentanil combined with ropivacaine in epidural labor analgesia in latent period

目的:探讨舒芬太尼复合罗哌卡因用于潜伏期硬膜外分娩镇痛的临床效果。方法:将某院分娩且行分娩镇痛的产妇102例作为研究对象,通过随机数表法将其分为2组,各51例。对照组采取芬太尼复合罗哌卡因分娩镇痛,观察组采取舒芬太尼复合罗哌卡因分娩镇痛。观察2组分娩方式、产程时间、产后出血量、宫缩素使用情况、疼痛程度及新生儿5 min Apgar评分、不良反应发生情况等。结果:2组宫口开至3 cm,5 cm,8 cm,10 cm时视觉模拟评分(VAS)比较,对照组高于观察组,差异有统计学意义(P<0.05);2组产程时间、产后出血量、新生儿Apgar评分、宫缩素使用率、剖宫产率、阴道助产率、不良反应发生率比较,差异无统计学意义(P>0.05)。结论:舒芬太尼复合罗哌卡因在潜伏期硬膜外分娩镇痛中效果确切,且不良反应少,是一种可靠、有效的分娩镇痛方案。

Objective：To analyze the clinical effect of sufentanil combined with ropivacaine in epidural labor analgesia in latent period. Methods ：102 pregnant women with delivery and labor analgesia in a hospital were selected and randomly divided into two groups, 51 cases in each group. The control group was given tentanyl combined with ropivacaine, while the obselaration group was treated with sutentanil combined with ropivacaine. The delivery mode, birth process time, postparlum bleeding volume, use of oxytocin, pain degree, neonatal 5rain Apgar score, and adverse reactions in the two groups were observed and analyzed. Results：The visual analogue scale from cervical dilation at 3cm, 5cm, 8cm, and 10cm in the control group was statistically higher than that in the observation group （ P 〈 0.05 ）. There was no statistical ditterence in terms of the birth process time, postpartum bleeding volume, neonatal Apgar score, use of oxytocin, cesarean section rate, vagina delivery rate and incidence of adverse reactions between the two groups （ P 〉 0.05 ）. Conclusion：Sutentanil combined with mpivacaine in epidural labor analgesia in latent period is ettective and has less adverse reactions, which is a reliable and ettective labor analgesia regimen.